Drug
Htx 034 Low Dose
Htx 034 Low Dose: highest development phase Phase 1/2, developed by Heron Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Heron Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| HTX-034 low dose NCT04398329 | Phase 1/2 | Bunions |
Latest
No recent events.
Follow Htx 034 Low Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.